These responses may be critical in reducing the clinical symptoms associated with COVID-19 disease, as evidenced by longitudinal follow-up of patients with SARS-CoV-2 infection, where rapid CD4+ T cell responses in acute COVID-19 were shown to be associated with mild disease and accelerated viral clearance, and early appearance of SARS-CoV-2–specific T cells was associated with shorter duration of infection (17). Here, CD4 is linked to COVID-19.